INTRODUCTION
Development of the human brain is a complex process, which initiates in the prenatal stage and is completed in the first years of childhood. Corticogenesis involves processes such as proliferation, migration and differentiation that leads to the formation of the mature convoluted cortex. Defects in neuronal migration may result in lissencephaly that is a severe brain malformation characterized by the lack of most gyri and sulci. There are two types of lissencephaly: type I or 'classical lissencephaly', where four layers of abnormally positioned neurons are observed in the neocortex, and type II or 'cobblestone' lissencephaly, where the cortex is unlayered (1) . Mutations in two different genes may result in type I lissencephaly: LIS1, an autosomal gene located on chromosome 17p13.3 (2) , and doublecortin, an X-linked gene (3, 4) . The phenotypic presentation of the patients is very similar, with delayed development and magnetic resonance imaging (MRI) analysis revealing both agyria and pachygyria. However, whereas the frontal brain is more affected in patients with mutations in doublecortin, the parietal and occipital cortex are more affected in the case of mutations in LIS1 (5) . Mutations in the X-linked DCX gene result in lissencephaly in males or subcortical laminar heterotopia, i.e. 'double cortex', in females (3, 4) . The milder phenotype seen in females consists of a brain with bilateral plates or bands of gray matter located beneath the cortex and ventricle but separated from both, hence the descriptive term double cortex (6) . Mutations in LIS1 are hemizygous and the disease results from reduced gene dosage (2) . The primary amino acid sequence reveals that LIS1 contains seven WD (tryptophan-aspartic acid) repeats (2, 7, 8) , positioning LIS1 in a large group of proteins known to be involved in multiple protein interactions (9) . Although LIS1 was isolated as a subunit of platelet-activating factor acetylhydrolase Ib (10) , the protein also interacts with microtubules and affects microtubule dynamics (11) . The product of the doublecortin gene associates with and stabilizes microtubules (12) (13) (14) . We have identified the tubulin-binding domain of DCX and found it to be an evolutionarily conserved repeat (15) . Interestingly, most lissencephaly-causing amino acid substitutions in DCX cluster within the repeated domain (15) . Our combined results emphasize the importance of LIS1-microtubule and DCX-microtubule interactions during normal and abnormal brain development. As LIS1 and DCX have similar functions, we raised the hypothesis that they may interact directly. Our results suggest that LIS1 and DCX are co-expressed, interact and can function in the same protein complex in the developing brain.
RESULTS

Co-expression and co-localization of LIS1 and DCX
To follow expression of LIS1 and DCX during brain development we examined RNA expression in the dorsal telencephalon of mouse embryos beginning at embryonic day E10.5-E15.5, when the process of neurogenesis is active. Although LIS1 is clearly expressed at all time points examined, the expression of DCX initiates at E11.5 and increases later on (Fig. 1) . This result reflects the notion that both genes are expressed in the developing brain as has been shown (13, 16) . Next, we examined whether the two protein products are co-expressed in the same + To whom correspondence should be addressed. Tel: +972 8 9342319; Fax: +972 8 9344108; Email: orly.reiner@weizmann.ac.il neurons. As can be seen (Fig. 2) , the staining in neurons suggested co-localization of both proteins. However, the co-localization in the neurons is partial: quite strikingly, LIS1 antibodies react with thin neurites that DCX antibodies do not recognize. Both antibodies stain the soma and the thick neurites. Nevertheless, DCX immunostaining is lacking from at least one of the neurites that may be the future axon, suggesting polarity in DCX neuronal localization. In order to further investigate the co-localization, we transiently transfected COS-7 cells that endogenously express LIS1 with FLAG-tagged DCX and immunostained them. The transfected cells depict a significant overlap in the staining pattern (Fig. 3) . The DCX-transfected cells exhibit a marked change in their morphology in comparison with untransfected cells, caused by the bundled microtubules. This co-localization prompted us to investigate further potential interactions between LIS1 and DCX. Expression of Lis1 and DCX RNA in the dorsal telencephalon. Total RNA (7.5 µg) from the dorsal telencephalon of several mouse embryos from different embryonic days (E10.5-E15.5) was loaded onto an agarose gel and northern blotted. The blot was probed with Lis1, DCX and GAPDH probes as indicated. The four Lis1 mRNA species are indicated by arrowheads. DCX expression is visible at E11.5. Loading was assessed by hybridization with GAPDH. 
LIS1 and DCX interact in vitro
Several assays performed with recombinant proteins demonstrated a possible interaction between LIS1 and DCX. We used BIAcore, a system that measures changes in surface plasmon resonance that are proportional to the changes in the mass of molecular species bound to the surface (17) (18) (19) (20) . The mass differences measured reflect the kinetic events including association and dissociation of complexes that are composed of immobilized molecules and other molecules brought into contact with them in the flow cell. Binding of DCX to immobilized LIS1 is specific and dose dependent as it is proportional to the amount of bound LIS1 protein (ligand levels) (Fig. 4) . This was the first indication that LIS1 and DCX can interact directly without additional mediators.
Mapping of interaction domains
LIS1-DCX heterodimerization and DCX homodimerization.
To map the region within DCX that interacts with LIS1, we used several glutathione S-transferase (GST)-DCX fragments (schematic presentation shown in Fig. 5A ): full-length DCX (amino acids 1-360), amino acids 110-360, amino acids 1-213 (12), pep1 (amino acids 51-135), pep2 (amino acids 178-259), and pep(1+2) (amino acids 51-259) (15) . Full-length GST-DCX pulled down recombinant LIS1 (Fig. 5B) , as well as in vitro translated LIS1 (Fig. 5C ) and endogenous LIS1 from embryonic brain extract (Fig. 5D) . The smallest portion of DCX that pulls . LIS1-DCX interaction using surface plasmon resonance. LIS1 was immobilized to the sensor chip at two densities [7700 and 6200 resonance units (RU)]. The time is in minutes. A blank channel was prepared by a flow buffer instead of protein solution during the immobilization phase. GST-DCX (5 mM) was introduced to the immobilized LIS1 at a constant flow rate of 10 ml/min. As can be seen in the two channels GST-DCX is bound by the LIS1 protein in a dose-specific manner. down LIS1 is pep1. Our previous results (15) identified this region as an evolutionarily conserved domain. This peptide was also shown to pull down tubulin from brain extract, but did not pull down purified tubulin (15) . The peptide probably recruited additional proteins from the extract that mediated its interaction with tubulin. It may be that LIS1 mediates pep1-tubulin interaction.
In addition, we detected in vitro homodimerization of DCX. This was demonstrated by pull-down of recombinant DCX tagged with 6×His or GST (Fig. 6A) , and in COS cell extracts where FLAG-DCX was pulled down by GST-DCX (Fig. 6B ). The homodimerization domain was mapped to the pep1 domain of DCX as described previously (Fig. 6 ). Our finding of a common interaction region responsible for DCX homodimerization and LIS1-DCX interaction predicted that LIS1 and DCX compete.
In a similar fashion, we mapped the reciprocal regions in LIS1 that are important for DCX binding. Previous studies with LIS1 have indicated that simple truncations result in a protein that is not folded properly (21) . However, our recent work suggests that LIS1 is a β-propeller similar to the β-subunit of G proteins (21, 22) and therefore it is likely that each WD will retain its structure as an anti-parallel β sheet. Based on this assumption, we cloned individual WD domains of LIS1 and the N-terminal portion (schematic presentation shown in Fig. 7A ), translated them in vitro and used GST-DCX in a pull-down experiment. The results were plotted as the percentage of input protein that was pulled down by GST-DCX. According to this type of analysis the main WD repeat that participates in the LIS1-DCX interaction is WD7.
LIS1 and DCX interact in vivo.
To examine LIS1-DCX interaction in vivo, 293T cells were transiently transfected with PECE-FLAG-DCX constructs. The constructs harbor normal DCX or mutations that were identified in patients (T203R, R192W, Y125H, D62N, R59L and S47R) (3, 4, 15) . Immunoprecipitation using anti-FLAG antibodies successfully precipitated endogenous LIS1 from transfected cells, but not from mocktransfected cells (Fig. 8A) . DCX mutations were expressed, as Figure 6 . In vitro DCX homodimerization. (A) 6×His-DCX expressed and purified from bacterial cells was pulled down by GST fusion full-length and shorter fragments of DCX (pep1, pep2 and pep1+2). GST was used as a negative control. (B) FLAG-tagged DCX was transfected to 293T cells and pulled down by GST fusion full-length and shorter fragments of DCX (pep1, pep2 and pep1+2). GST was used as a negative control. From both panels it is clear that the minimal fragment required for this in vitro interaction is pep(1) (amino acids 51-135) of DCX. demonstrated by western blot using anti-FLAG antibodies (Fig. 8B) .
Next we wanted to test whether LIS1-DCX interactions occurred in the developing mouse brain. LIS1 from embryonic brain extracts was immunoprecipitated using mouse monoclonal anti-LIS1 antibodies, protein A/G beads or anti-GAD antibodies (data not shown). Co-immunoprecipitation with DCX was checked by immunoblotting with anti-DCX antibodies (Fig. 8C) . A DCX-immunoreactive band was detected specifically in the anti-LIS1 precipitate but not in the control precipitates. These studies suggest that LIS1 and DCX form a complex in the developing brain.
LIS1, DCX and tubulin.
To explore whether LIS1 and DCX affect microtubule formation in an additive or competitive way, we measured the assembly rate of tubulin using a light scattering assay (Fig. 9 ). This assay is based on the increase in optical scattering as microtubules polymerize, measured as an effective optical density. Addition of DCX to tubulin increased the assembly rate of tubulin as shown previously (12) . Addition of LIS1 to tubulin without DCX also increased the polymerization rate of microtubules (Fig. 9) . When LIS1 was added to tubulin in the presence of DCX the assembly rate of tubulin increased in an additive fashion (Fig. 9) . If LIS1 and DCX share the same tubulin binding sites we would expect the net result not to be additive since the proteins compete for the same interaction region. The results of this experiment suggest that LIS1 and DCX bind to different sites on tubulin or that they share common sites. If the latter possibility is correct and they share common sites, the additive affect may be explained by altered binding affinities.
To differentiate between these two possibilities we designed a competition assay where both proteins were added to preassembled microtubules. In the first experiment, increasing amounts of DCX were added to constant amounts of LIS1 (Fig. 10A) ; whereas in the second experiment, increasing amounts of LIS1 were added to constant amounts of DCX (Fig. 10B) . The distribution of LIS1 between the insoluble (pellet) microtubule fraction and the soluble (supernatant) fraction was examined by western blot analysis. Interestingly, the results changed depending on the order in which the components were added. When increasing amounts of DCX were added to constant amounts of LIS1, DCX competes LIS1 out and more LIS1 was found in the supernatant fraction (Fig. 10A) . When increasing amounts of LIS1 were added to constant amounts of DCX, the affinity of LIS1 to microtubules increased and more LIS1 was found in the pellet fraction (Fig. 10B) . Addition of LIS1 did not change the affinity of DCX to the microtubule cytoskeleton (data not shown), and DCX was found mainly in the pellet fraction. In these experiments the net amount of polymerized microtubules did not change (Fig. 10C) .
DISCUSSION
To investigate molecular mechanisms involved in lissencephaly, we tested for an interaction between LIS1 and DCX using several independent methods. The notion that two genes, Figure 9 . DCX and LIS1 affect tubulin assembly rate in vitro. The assembly rate of tubulin was measured using a light scattering assay. The concentration of tubulin used was 15 mM. The optical absorbance was recorded every minute for 40 min. The recombinant proteins used were GST, GST-DCX and GST-LIS1, each at a final concentration of 7.5 mM. The recombinant proteins were added prior to the measurement. Addition of the two proteins together (each at a concentration of 7.5 mM) shows that they have an additive effect on tubulin polymerization. which when mutated give rise to a similar phenotype, can physically interact has been demonstrated in the past. Two gene products involved in autosomal dominant polycystic disease, PKD1 and PKD2, interact via similar coiled-coil domains in the C-terminal region (23, 24) . Naturally occurring pathogenic mutations in PKD1 and PKD2 disrupt their associations (23) . An additional example are two genes involved in tuberous sclerosis (TSC) an autosomal dominant disorder characterized by a broad phenotypic spectrum that includes seizures, mental retardation, renal dysfunction and dermatological abnormalities. Mutations in the TSC1 and TSC2 genes were found to be responsible for the disease. The two gene products can interact with each other (25, 26) . Careful investigations suggested the presence of additional proteins within this complex (27) . It has been proposed that one of these proteins modifies the self-aggregation of the other.
We have shown that LIS1 and DCX are co-expressed in the developing brain. Furthermore, the two proteins co-localize in transfected COS cells and partially co-localize in primary neurons. In neuronal cells it was observed that DCX localization is polar. We plan to investigate this issue more carefully in the future, as polarized morphology of neurons, typified by a single long axon and several short dendrites is a fundamental morphological feature (28) . LIS1 immunostaining, on the other hand, was obvious in very fine dendrites. This may be related to the recent observation that heterotopic pyramidal neurons in Lis1 +/-mice were stunted and possessed fewer dendritic branches (29) .
The actual interaction of the two gene products was demonstrated as the recombinant proteins interacted in the BIAcore and pull-down assays. Mapping of the interaction domains was feasible using pull-down assays with short peptides of either LIS1 or DCX. The minimal interacting regions are the last WD repeat in LIS1 (WD7) and pep1 in DCX. In addition to DCX heterodimerization, we also showed that DCX is capable of homodimerization in vitro. The interaction domains of DCX with both DCX or LIS1 were mapped to an evolutionarily conserved region (pep1, amino acids 52-133) (15) , which includes the tubulin binding site as well. The existence of such a complex in vitro suggests that it may also function in vivo. Indeed, the LIS1-DCX interaction in vivo was demonstrated by co-immunoprecipitation of transiently expressed DCX in transfected cells with endogenous LIS1. Moreover, the two proteins were co-immunoprecipitated in embryonic brain extracts that express both LIS1 and DCX. In transfected cells, we tested the interaction of six naturally occurring pathogenic mutations of DCX with LIS1. Some of the mutations were not expected to alter interactions because they are located outside the interaction domain mapped using the pull-down experiments. However, point mutations may affect protein folding; therefore, we thought that it may be useful to test all the mutated proteins we had. The mutations that we tested did not interfere with the association between LIS1 and DCX.
We have previously demonstrated that both LIS1 and DCX interact with tubulin therefore, we cannot exclude the possibility that in vivo interactions between DCX and LIS1 are mediated by tubulin. Thus, we tested the effect of both proteins on microtubule polymerization. Using a light scattering assay it was observed that the addition of both proteins result in an additive effect on microtubule polymerization. This suggested two possibilities: (i) LIS1 and DCX have different binding sites thus their binding is additive; or (ii) these proteins share regions but perhaps the interaction of one with tubulin changes the binding affinity of the other. In order to distinguish between these possibilities we designed a competition assay where increasing concentrations of DCX were added to constant concentrations of LIS1 with pre-assembled microtubules or vice versa. Interestingly, the results were dependent on the order of the added components (a schematic model is shown in Fig. 11 ). In this set of experiments LIS1 was usually found associated with the microtubule pellet fraction (Fig. 11A) ; however, when DCX was added it competed with LIS1 and more was found in the soluble fraction (Fig. 11B) . DCX, on the other hand was completely associated with microtubules regardless of LIS1 concentration ( Fig. 11C and D) . When LIS1 was added to the microtubule-DCX complex a larger amount of LIS1 was then associated with the microtubule pellet fraction (Fig. 11D) . This alteration in the binding affinity of LIS1 may be due to a conformational change in the microtubles themselves ( Fig. 11C and D) . Can this experiment reflect in vivo behaviour of these molecules? Can the presence of one molecule affect the function of the other? Although this indeed is far fetched, there may be some evidence to support this hypothesis. In COS cells transfected with DCX, we noticed a shift of endogenous LIS1 (usually partially associated with microtubules) to be more associated with microtubules. This question will be addressed more directly in the future using DCX transgenic mice.
Is LIS1-DCX interaction relevant to the lissencephaly phenotype? We believe that it is. A recent study (30) of immunohistochemical expression of DCX demonstrated abnormal localization in Miller-Dieker syndrome (involving LIS1 deletion) and Fukuyama congenital muscular dystrophy but not in other migration disorders. This result taken together with our findings provides further evidence for a possible endogenous function for LIS1-DCX-tubulin complex.
MATERIALS AND METHODS
Northern blot
Total mRNA for northern analysis was isolated using Tri Reagent (Sigma, Rehovot, Israel) according to the manufacturer's protocol. Northern blots were performed as described by Ausubel et al. (31) .
Cell culture
COS-7 and 293T cells were grown at 37°C with 5% CO 2 and 95% air in DMEM nutrient medium supplemented with 10% fetal bovine serum, 4 mM glutamine, 100 U/ml penicillin and 0.1 mg/ml streptomycin. Cultures were split using standard trypsinization procedures. Cells were transfected using the BES transfection procedure (31) . Transfected cells were harvested or stained after 48 h. Efficiency of transfections was estimated using an EGFP expression vector (Clontech, Palo Alto, CA).
Constructs
The different WDs were amplified by PCR using the following primers:
WD1, 5′-ATGCATCCATGGATTCCCCGTCCGCCAGAAAAATAT-3′ and 5′-GAAGATCTTCAATCCCACACCTTAATTGTAGCATC-3′; WD2, 5′-ATGCATCCATGGTATGAGACTGGAGATTTTGAACGA-3′ and 5′-GAAGATCTTCAATCCCATAGTTTAATGGTCATA TC-3′; WD3, 5′-ATGCATCCATGGTTTCAGGGCTTTGAATGCATCAGA-3′ and 5′-GAAGATCTTCATTCCCACATT TTTATAGTTTTATC-3′; WD4, 5′-ATGCATCCATGGGTGCAAACTGGCTACTGTGTGAAG-3′ and 5′-GAAGATCTT CAGACCCATACACGCACAGTCTGGTC-3′; WD5, 5′-ATGCATCCATGGGTAGCAACAAAGGAATGCAAGGCT-3′ and 5′-GAAGATCTTCAATCCCACATCTTAATAGTCTTGTC-3′; WD6, 5′-ATGCATCCATGGGTCAGTACTGGCATGTGCCTTATG-3′ and 5′-GAAGATCTTCAATCCCATACGCGTAGGGTCTTGTC-3′; WD7, 5′-ATGCATCCATGGTACAAGAACAAGCGATGCATGAAG-3′ and 5′-GAAGATCTTCAACGGCACTCCCACACTTTTACTGT-3′.
All fragments were then ligated into the expression vector pRSET (Invitrogen, Leek, The Netherlands). FLAG-tagged and GST-tagged DCX constructs were described previously (12, 15) .
Antibodies
Mouse polyclonal anti-doublecortin antibodies were produced against GST-DCX (12) using conventional protocols (32) . Rabbit polyclonal anti-LIS1 antibodies (R19) were affinity purified (11) . Anti-FLAG M2 monoclonal antibodies were purchased from Sigma. All secondary antibodies were from Jackson Immunoresearch (West Grove, PA); peroxidaseconjugated affinipure goat anti-mouse IgG (H+L), lissamine rhodamine-conjugated affinipure goat anti-mouse or anti-rabbit IgG (H+L), FITC-conjugated affinipure goat anti-mouse or anti-rabbit IgG (H+L).
Immunostaining
Briefly, transfected COS-7 cells were plated on glass coverslides. After 48 h they were washed twice with phosphate-buffered saline (PBS), then fixed and permeabilized simultaneously as described (11) . Primary neurons derived from embryonic rat hippocampus were obtained from Dr Tony Futerman. The neurons were fixed for 20 min with 4% PFA, 4% sucrose at On the other hand, increasing concentrations of LIS1 added to the DCX-microtubule complexes caused LIS1 to bind microtubules with a higher affinity (plausibly due to a conformational change that may be in the microtubule moiety). As a result, more of LIS1 is bound to microtubule. 37°C and permeabilized for 5 min with 0.25% Triton X-100. After fixation the cells were incubated with 30 ml of the first antibody for 60 min at room temperature, then washed three times in PBS and incubated for 60 min with 30 ml of fluorescentconjugated secondary antibodies. The coverslips were washed three times in PBS, drained and mounted. The immunostaining was visualized using an Olympus microscope (IX50 model; Hamburg, Germany) using the appropriate filters. Photography was with Kodak 160T film. Neurons were observed under a Bio-Rad (Hercules, CA) confocal microscope.
GST pull-down assay
GST fusion proteins were used for pull-down experiments with either recombinant LIS1 protein or brain extract. Recombinant 6×His-LIS1was expressed in insect cells by Baculovirus [described by Sapir et al. (11) ] and purified on Ni-NTA beads (Qiagen, Hilden, Germany). LIS1 and the different WD peptides were produced in the Rabbit Reticulocyte TnT System (Promega, Madison, WI) with [ 35 S]methionine. In each pull-down experiment, 10 ml of the labeled reaction was used. E17 brain extract was prepared in T-T buffer (20 mM TrisHCl pH 8, 100 mM NaCl, 1 mM EDTA, 0.1% Triton-X), supplemented with protease inhibitors (Sigma).
Recombinant proteins or brain extract were incubated with 10 mg of GST-DCX, GST-pep1, GST-pep2, GST-pep(1+2) and GST as control at 4°C for 15 h. Glutathione beads (20 ml) in 300 ml of T-T buffer were added to the protein mixture and rotated for 30 min at room temperature. After four washes with T-T buffer, 2× sample buffer was added and the beads were boiled and subjected to SDS-PAGE gel analysis. A western blot was performed with anti-LIS1 antibodies (monoclonal clone 210).
6×His pull-down assay
Fifteen milligrams of 6×His-LIS1 were incubated with embryonic brain extract (prepared as described) at 4°C for 15 h. Ni-NTA beads (20 mg; Qiagen) in 400 ml of sonication buffer (300 mM NaCl, 50 mM sodium phosphate buffer pH 8.0) with 10 mM imidazole were added to the protein mixture and rotated at 4°C for 3 h. The beads were washed four times with sonication buffer with 30 mM imidazole and eluted with 20 µl of sonication buffer and 200 mM imidazole. After elution 5× sample buffer was added and the beads were run on an SDS-PAGE gel. A western blot was performed with mouse polyclonal anti-DCX antibodies.
Immunoprecipitation assay
Immunoprecipitation was performed in 293T cells using M2 beads (Sigma), or from E17 brain extract (prepared as described) using anti-LIS1 (monoclonal clone 338) and anti-GAD (monoclonal control) antibodies. Cell extract was prepared in IP buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% Triton X-100), supplemented with protease inhibitors (Sigma). Each 10 cm plate was washed with PBS, put on ice and scraped with 1 ml of cold IP buffer. The cells were incubated on ice for 15 min and were vortexed for 10 s every 5 min. After centrifugation at 9000 r.p.m. for 15 min at 4°C, 0.5 ml of the supernatant was rotated with M2 beads for 3 h at 4°C. Brain extract (∼500 mg) was incubated with 5 ml of antibody for 15 h at 4°C and then rotated with 20 ml A/G protein beads for 2 h at 4°C. Beads were washed four times with T-T or IP buffer, respectively. Sample buffer (×2) was added and the beads were boiled and subjected to an SDS-PAGE gel. A western blot was performed with anti-LIS1 (monoclonal clone 210) or anti-DCX antibodies.
Rate measurements
Tubulin was purified as described (11) . The rate of tubulin assembly into polymers was monitored using a light scattering assay (12, 15) . Purified tubulin was diluted in PEM buffer (100 mM PIPES pH 6.9, 1 mM MgSO4, 1 mM EGTA) supplemented with 1 mM GTP, to a final concentration of 15 µM. GST-DCX, GST-LIS1 and GST (7.5 µg) were added to the purified tubulin subunits prior to measurement. Absorbance was measured at 350 nm at 1 min intervals in a Uvicon spectrophotometer (Kontron Instruments, Vineland, NJ) equipped with temperature controlled cells. Switching the temperature to 37°C induced assembly.
Competition assay
Sedimentation experiments were performed essentially as described (13) . After microtubules (5 µM) were pre-assembled for 15 min at 37°C, GST-LIS1 and GST-DCX proteins were added. In each experiment one protein was at a constant concentration (2.5 µM) and the other at increasing concentrations (0-5 µM). All reactions were divided into three: 60% for Coomassie staining and 10% for western blot analysis with anti-DCX and anti-LIS1 antibodies, respectively.
